+ Home
+ Contact
Trials open for enrolment


LG740

LG740 is a treatment for refractory Leukemia and Lymphoma. This clinical trial is currently recruiting patients.
View details

 
 
 
Background_waves
Background_footer
© Copyright 2008 Lentigen Corp. All Rights Reserved.    + Privacy Policy    + Terms of Use